Amarin Corp. (AMRN) –
-
Form 4 AMARIN CORP PLC\UK For: Apr 18 Filed by: Cohen Paul
-
Form 4 AMARIN CORP PLC\UK For: Apr 18 Filed by: Sullivan Diane E.
-
Form 4 AMARIN CORP PLC\UK For: Apr 18 Filed by: O'Connor Oliver
-
Form 4 AMARIN CORP PLC\UK For: Apr 18 Filed by: Sterling Louis III
-
Form 4 AMARIN CORP PLC\UK For: Apr 18 Filed by: DiPaolo Mark
-
Form 4 AMARIN CORP PLC\UK For: Apr 18 Filed by: Odysseas Kostas D
-
Form 4 AMARIN CORP PLC\UK For: Apr 18 Filed by: Horn Keith
-
Form 4 AMARIN CORP PLC\UK For: Apr 18 Filed by: Bonfiglio Patrice Eadon
-
Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024
-
Amarin Corp. (AMRN) Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24
-
Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24
-
New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups
-
Amarin Corp. (AMRN) Issues Update on VAZKEPA Intellectual Property Portfolio in Europe
-
Form 8-K AMARIN CORP PLC\UK For: Apr 03
-
Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe
-
Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo
-
Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo
-
Form ARS AMARIN CORP PLC\UK For: Dec 31
-
Form DEF 14A AMARIN CORP PLC\UK For: Apr 18
-
Amarin Corp. (AMRN) Tops Q4 EPS by 3c, offers outlook
-
Form 10-K AMARIN CORP PLC\UK For: Dec 31
-
Form 8-K AMARIN CORP PLC\UK For: Feb 29
-
Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
-
Amarin to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference on February 29, 2024
-
Form PRE 14A AMARIN CORP PLC\UK For: Feb 12
-
Form 4 AMARIN CORP PLC\UK For: Feb 01 Filed by: Berg Aaron
-
Form 4 AMARIN CORP PLC\UK For: Feb 01 Filed by: Ketchum Steven B
-
Form 4 AMARIN CORP PLC\UK For: Feb 01 Filed by: Reilly Thomas Charles
-
Form 4 AMARIN CORP PLC\UK For: Jan 31 Filed by: Berg Aaron
-
Form 4 AMARIN CORP PLC\UK For: Jan 31 Filed by: Ketchum Steven B
-
Form 4 AMARIN CORP PLC\UK For: Jan 31 Filed by: Reilly Thomas Charles
-
Form 8-K AMARIN CORP PLC\UK For: Jan 25
-
Form 4 AMARIN CORP PLC\UK For: Jan 22 Filed by: Holt Patrick
-
Amarin Corp. (AMRN) CEO Issue Letter to Shareholders
-
Amarin Chairman & CEO Issue Letter to Shareholders
-
Amarin Chairman & CEO Issue Letter to Shareholders
-
Form 4 AMARIN CORP PLC\UK For: Jan 10 Filed by: Ketchum Steven B
-
Form 4 AMARIN CORP PLC\UK For: Jan 10 Filed by: Reilly Thomas Charles
-
Form 4 AMARIN CORP PLC\UK For: Jan 10 Filed by: Berg Aaron
-
Amarin Corp. (AMRN) Provides Preliminary Fourth Quarter 2023 Selected Financials and Outlines Key Priorities For 2024
-
Form 8-K AMARIN CORP PLC\UK For: Jan 10
-
Amarin Provides Preliminary Fourth Quarter 2023 Selected Financials and Outlines Key Priorities For 2024
-
Form 4 AMARIN CORP PLC\UK For: Jan 04 Filed by: Ketchum Steven B
-
Form 4 AMARIN CORP PLC\UK For: Jan 04 Filed by: Berg Aaron
-
Form 4 AMARIN CORP PLC\UK For: Dec 29 Filed by: Ketchum Steven B
-
Form 4 AMARIN CORP PLC\UK For: Dec 29 Filed by: Berg Aaron
-
Form 4 AMARIN CORP PLC\UK For: Dec 12 Filed by: Ketchum Steven B
-
Form 144 AMARIN CORP PLC\UK Filed by: Ketchum Steven B
-
Amarin to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
Form SC 13G/A AMARIN CORP PLC\UK Filed by: MORGAN STANLEY
Back to AMRN Stock Lookup
